Chicago, IL (June 17, 2020): The Hematology/Oncology Pharmacy Association (HOPA), an organization that provides education, networking, cutting-edge resources, advocacy and advancement opportunities to the pharmacist community, launched the Core Competency Program.
This program is fundamental for pharmacists new to oncology pharmacy. The program contains 12 learning modules that give learners access to high-quality education on a flexible learning platform. The content focuses on various treatment options, chemotherapy safety, chemotherapy admixture, pharmacology and chemotherapy toxicity and prevention/management.
Upon completion of the program, learners are deemed competent to practice in oncology pharmacy.
“This program leverages the expertise of HOPA pharmacists in providing quality education for interdisciplinary clinicians new to the field of oncology pharmacy,” said Emily Mackler, Director of Clinical Quality Initiatives at Michigan Oncology Quality Consortium (MOQC) and HOPA Board Member. “The comprehensiveness of the program, scheduled content updates, and the focus on safety and quality of oncology care makes this an essential education opportunity for community hospitals, retail pharmacies and pharmacists looking to advance their careers.”
About Hematology/Oncology Pharmacy Association (HOPA):
Hematology/Oncology Pharmacy Association (HOPA) is a nonprofit, education-based organization formed in 2004 to help oncology and hematology pharmacy practitioners and their associates the best possible cancer care. HOPA supports research, provides education, encourages professional development and advocates for health policy issues that improve patient care.
